These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36156071)

  • 1. Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer.
    Khayati K; Bhatt V; Lan T; Alogaili F; Wang W; Lopez E; Hu ZS; Gokhale S; Cassidy L; Narita M; Xie P; White E; Guo JY
    Cancer Res; 2022 Dec; 82(23):4429-4443. PubMed ID: 36156071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient systemic autophagy ablation irreversibly inhibits lung tumor cell metabolism and promotes T-cell mediated tumor killing.
    Nunn K; Yanxiang Guo J
    Autophagy; 2023 Jun; 19(6):1879-1881. PubMed ID: 36314942
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Deneka AY; Kopp MC; Nikonova AS; Gaponova AV; Kiseleva AA; Hensley HH; Flieder DB; Serebriiskii IG; Golemis EA
    Cancer Res; 2021 Jul; 81(13):3717-3726. PubMed ID: 34006524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy is required for glucose homeostasis and lung tumor maintenance.
    Karsli-Uzunbas G; Guo JY; Price S; Teng X; Laddha SV; Khor S; Kalaany NY; Jacks T; Chan CS; Rabinowitz JD; White E
    Cancer Discov; 2014 Aug; 4(8):914-27. PubMed ID: 24875857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy.
    Zhang W; Dong YZ; Du X; Peng XN; Shen QM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2444-2452. PubMed ID: 30964170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
    Deng H; Gao Y; Trappetti V; Hertig D; Karatkevich D; Losmanova T; Urzi C; Ge H; Geest GA; Bruggmann R; Djonov V; Nuoffer JM; Vermathen P; Zamboni N; Riether C; Ochsenbein A; Peng RW; Kocher GJ; Schmid RA; Dorn P; Marti TM
    Cell Mol Life Sci; 2022 Jul; 79(8):445. PubMed ID: 35877003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.
    Sakitani K; Hirata Y; Hikiba Y; Hayakawa Y; Ihara S; Suzuki H; Suzuki N; Serizawa T; Kinoshita H; Sakamoto K; Nakagawa H; Tateishi K; Maeda S; Ikenoue T; Kawazu S; Koike K
    BMC Cancer; 2015 Oct; 15():795. PubMed ID: 26496833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.
    Ohtani S; Iwamaru A; Deng W; Ueda K; Wu G; Jayachandran G; Kondo S; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jul; 67(13):6293-303. PubMed ID: 17616688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.
    Van Nostrand JL; Brisac A; Mello SS; Jacobs SB; Luong R; Attardi LD
    Cancer Discov; 2015 Jun; 5(6):622-35. PubMed ID: 25813352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
    Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TECPR1 Induces Apoptosis in Non-Small Cell Lung Carcinoma via ATG5 Upregulation-Induced Autophagy Promotion.
    Cao L; Lin F
    Ann Clin Lab Sci; 2022 Jul; 52(4):580-592. PubMed ID: 36197771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 14. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.
    Cao Q; You X; Xu L; Wang L; Chen Y
    Autophagy; 2020 Jul; 16(7):1236-1247. PubMed ID: 31448672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling.
    Arora S; Singh P; Tabassum G; Dohare R; Syed MA
    Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5/ATG12-mediated autophagy via miR-372-3p.
    He H; Song X; Yang Z; Mao Y; Zhang K; Wang Y; Su B; Li Q; Chen H; Li Y
    Cell Death Dis; 2020 Oct; 11(10):883. PubMed ID: 33082306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
    Liu X; Li J; Huang Q; Jin M; Huang G
    Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
    Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
    Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors.
    Lashinger LM; O'Flanagan CH; Dunlap SM; Rasmussen AJ; Sweeney S; Guo JY; Lodi A; Tiziani S; White E; Hursting SD
    Cancer Metab; 2016; 4():18. PubMed ID: 27651895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism.
    Strohecker AM; White E
    Autophagy; 2014 Feb; 10(2):384-5. PubMed ID: 24362353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.